BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16044341)

  • 1. Role of Na+, K+-ATPase alpha1 subunit in the intracellular accumulation of cisplatin.
    Kishimoto S; Kawazoe Y; Ikeno M; Saitoh M; Nakano Y; Nishi Y; Fukushima S; Takeuchi Y
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):84-90. PubMed ID: 16044341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY; Rogers PM; Kelland LR
    Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Na+, K(+)-ATPase on intracellular accumulation of cis-diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Matsuda T
    Anticancer Res; 1998; 18(2A):1085-9. PubMed ID: 9615770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of intracellular nm23-H1 prevents cisplatin-induced DNA damage in oesophageal cancer cells: possible association with Na(+), K(+)-ATPase.
    lizuka N; Miyamoto K; Tangoku A; Hayashi H; Hazama S; Yoshino S; Yoshimura K; Hirose K; Yoshida H; Oka M
    Br J Cancer; 2000 Nov; 83(9):1209-15. PubMed ID: 11027435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and characterization of an acquired cisplatin-resistant subline in a human osteosarcoma cell line.
    Asada N; Tsuchiya H; Ueda Y; Tomita K
    Anticancer Res; 1998; 18(3A):1765-8. PubMed ID: 9673402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na+,K+-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B.
    Ahmed Z; Deyama Y; Yoshimura Y; Suzuki K
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):643-50. PubMed ID: 18545997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cycloheximide on Na,K-ATPase activity in cultured human lens epithelial cells.
    Cui G; Dean WL; Delamere NA
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2714-20. PubMed ID: 12147607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ouabain-resistant (Na+,K+)-ATPase enzyme activity in chemically induced ouabain-resistant C3H/10T1/2 cells.
    Shibuya ML; Miura T; Lillehaug JR; Farley RA; Landolph JR
    Mol Toxicol; 1989; 2(2):75-98. PubMed ID: 2562032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular uptake of an antitumor-active azole-bridged dinuclear platinum(II) complex in cisplatin-resistant tumor cells.
    Kishimoto S; Yasuda M; Suzuki R; Fukushima S
    Biometals; 2016 Dec; 29(6):1075-1083. PubMed ID: 27787693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Na+, K(+)-adenosine triphosphatase in the accumulation of cis-diamminedichloroplatinum(II) in human ovarian carcinoma cells.
    Andrews PA; Mann SC; Huynh HH; Albright KD
    Cancer Res; 1991 Jul; 51(14):3677-81. PubMed ID: 1648442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX; Luo Y; Qiu HM; Tang WX
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of PKC-dependent Na+ K+ ATPase phosphorylation in the rat kidney with chronic renal failure.
    Bertuccio CA; Arrizurieta EE; Ibarra FR; Martín RS
    Ren Fail; 2007; 29(1):13-22. PubMed ID: 17365905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Na(+)/K(+)-ATPase alpha1 siRNA and ouabain upon cell cycle in human hepatoma HepG2 cell and its mechanism].
    Xu ZW; Wang FM; Xu RC; Hu WL; Chen XY
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(12):813-7. PubMed ID: 20450619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human larynx carcinoma cells resistant to cis-diamminedichloroplatinum(II): mechanisms involved in the resistance.
    Beketić-Oresković L; Osmak M; Jaksić M
    Neoplasma; 1994; 41(3):163-9. PubMed ID: 7935985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of ouabain at different concentrations on growth of leukemia cells].
    Xu JW; Jin RM; Wang YR; Lin W; Meng B
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):259-62. PubMed ID: 19374807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell line.
    Kishimoto S; Miyazawa K; Terakawa Y; Ashikari H; Ohtani A; Fukushima S; Takeuchi Y
    Jpn J Cancer Res; 2000 Dec; 91(12):1326-32. PubMed ID: 11123433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The isoform-specific region of the Na,K-ATPase catalytic subunit: role in enzyme kinetics and regulation by protein kinase C.
    Duran MJ; Pierre SV; Carr DL; Pressley TA
    Biochemistry; 2004 Dec; 43(51):16174-83. PubMed ID: 15610011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exposure to sorbitol induces resistance to cisplatin in human non-small-cell lung cancer cell lines.
    Bando T; Fujimura M; Kasahara K; Shibata K; Shirasaki H; Heki U; Iwasa K; Ueda A; Tomikawa S; Matsuda T
    Anticancer Res; 1997; 17(5A):3345-8. PubMed ID: 9413170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Na,K-ATPase alpha1 subunit gene transcription in response to low K(+): role of CRE/ATF- and GC box-binding proteins.
    Wang G; Kawakami K; Gick G
    J Cell Physiol; 2007 Oct; 213(1):167-76. PubMed ID: 17477345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.